Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CI | HLT |
|---|---|---|
| Price | $266.19 | $312.80 |
| Change today | ▼ 0.78% | ▲ 1.81% |
| Market cap | $70.34B | $70.40B |
| Return, 3 months | -4.2% | -8.9% |
| Return, year to date | -1.6% | +9.0% |
| Return, 1 year | -6.6% | +19.1% |
| P/E (TTM) | 11.0 | 45.9 |
| P/B | 1.7 | -11.2 |
| P/E percentile vs own 5y | 12th | 59th |
| Dividend yield | 2.31% | 0.19% |
| Revenue growth (YoY, latest qtr) | +6.7% | +6.5% |
| Net profit growth (YoY) | +14.9% | +9.0% |
| Gross margin | 8.8% | 29.3% |
| Operating margin | 3.2% | 23.3% |
| Net margin | 2.3% | 12.7% |
| Return on equity | 15.5% | – |
| Analyst target vs. price | +26.9% | +14.5% |
| Analyst buy share | 69% | 71% |
| RSI (14) | 44 | 44 |
| 30-day volatility | 22.0% | 19.6% |
| Max drawdown, 1 year | -21.4% | -13.6% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.